Understanding Your Edwards SAPIEN M3 TMVR System Denial
The Edwards SAPIEN M3 is the first transcatheter mitral valve replacement (TMVR) system approved for patients with symptomatic moderate-to-severe mitral regurgitation who cannot undergo traditional surgery. This represents a breakthrough for patients with no other options. Insurance may require documentation of surgical ineligibility.
Common Reasons for Denial
- ! Prior authorization required
- ! Surgical candidacy not adequately ruled out
- ! Imaging requirements not met
- ! Must try MitraClip or other repair first
- ! Facility/center not approved
- ! New technology coverage limitations
How We Help
We help you document your mitral regurgitation severity, symptoms, heart team evaluation, reasons for surgical ineligibility, and why TMVR is your best option.
Some Types of Evidence We Can Use For Supporting Your Appeal
✓ SAPIEN M3 is the first transcatheter mitral valve replacement approved for transfemoral delivery.
✓ Clinical trials demonstrated significant reduction in mitral regurgitation and improvement in symptoms.
✓ Transcatheter options provide treatment for patients who previously had no surgical options.
✓ Heart team evaluation is essential for determining appropriate patient selection.
Patient Advocacy & Support Organizations
These organizations provide education, support, and advocacy for patients:
American Heart Association ↗
Leading nonprofit fighting heart disease through education, advocacy, and research.
Mended Hearts ↗
Peer support network for heart patients and their families.
Frequently Asked Questions
Ready to Fight Your Edwards SAPIEN M3 TMVR System Denial?
Our free AI-powered tool will help you generate a compelling appeal letter in minutes.
Disclaimer: Fight Health Insurance is not affiliated with, endorsed by, or partnered with any pharmaceutical manufacturer, healthcare provider, medical device company, or patient assistance program, including Edwards Lifesciences. All information provided is for educational and informational purposes only and does not constitute medical or legal advice. Please consult with your healthcare provider regarding treatment options and with your insurance company regarding coverage decisions.